Healthcare, politics and the NHS
November 24, 2010Research and Development Academy of Medical Sciences, Les Roes, NHS, clinical trials, clinical trials governance, evidence-based medicine
I have just participated in a consultation by the Academy of Medical Sciences on the regulation and governance of clinical …
Pharma manufacturing news in brief
November 23, 2010Manufacturing and Production Alpah Biologics, Alpha Biologics, Kemwell, Lonza, Phil Taylor, Roche
Facility updates from Roche, Alpha Biologics, Kemwell and Reinnervate, new contract services from Lonza and Patheon, plus a milestone in …
Brinsmead to be life sciences adviser to government
November 23, 2010Sales and Marketing Brinsmead, NHS, government, life sciences
Chris Brinsmead, chairman of AstraZeneca UK, has been made the government’s life sciences business adviser. He was appointed by universities …
Roche to develop diagnostic tools for Tarceva
November 23, 2010Sales and Marketing Genzyme, NSCLC, Roche, Tarceva, diagnostic
Roche has obtained a worldwide sub-license from Genzyme to develop a diagnostic kit for the detection of specific mutations for …
Vytorin cuts heart problems in kidney patients
November 23, 2010Sales and Marketing Merck, Vytorin, cardiovascular, simvastatin
Vytorin has been shown to reduce potentially heart problems in patients with chronic kidney disease (CKD) in a new study. …
Offshore outsourcing in Regulatory Affairs and Pharmacovigilance
November 22, 2010Sales and Marketing Kinapse, White paper
Based on Kinapse’s direct experience, we explore the emerging environment for regulatory and pharmacovigilance offshore outsourcing within the biopharmaceutical industry …
A new generation of analogues for valuing strategy
November 22, 2010Sales and Marketing Alex Blyth, MSI, forecasting, marketing, marketing strategy
Anyone who is involved in the planning of pharma marketing campaigns will know that the Holy Grail is trying to …
Chris King joins Synovate Healthcare
November 22, 2010Sales and Marketing Chris King, Synovate Healthcare, appointment, sales and marketing
Synovate has appointed Chris King head of its European Oncology Monitor within its specialist healthcare research division. He joins the …
Bayer’s challenger to Lucentis shows promise
November 22, 2010Research and Development, Sales and Marketing Bayer, Lucentis, Novartis, Regeneron, Roche, VEGF Trap-Eye, age-related macular degeneration, avastin, wet AMD
Phase III data for a new age-related macular degeneration (wet AMD) treatment show it is as good as Lucentis, the …
J&J and Takeda issue recall for cancer drug Velcade
November 22, 2010Manufacturing and Production J&J, JJ, Johnson & Johnson, Takeda Pharmaceuticals, Velcade, bortezomib, pharma manufacturing, product recalls
Johnson & Johnson has been affected by another product recall, on this occasion concerning the cancer drug Velcade (bortezomib) sold …
Daiichi-Sankyo cleared of rep misconduct
November 22, 2010Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, Daiichi Sankyo, Daiichi-Sankyo, Olmetec, PMCPA, olmesartan, pharma sales representative
Daiichi-Sankyo has been cleared of any wrongdoing in relation to the ABPI Code after one of its representatives was accused …
Pfizer’s axitinib impresses in head-to-head trial with Nexavar
November 22, 2010Research and Development, Sales and Marketing Kidney cancer, Nexavar, Pfizer, axitinib, mRCC, metastatic renal cell carcinoma
Pfizer’s axitinib has impressed in phase III trials assessing its efficacy as a second line treatment for renal cell carcinoma. …
Digital Pharma: E-Health and the European agenda
November 19, 2010Medical Communications Digital Agenda, Digital Pharma blog, EC, European Commission, Neelie Kroes, digital patients, e-health, electronic patient records
The European Commission wants all European patients to be given secure online access to their medical records by 2015 and …
Pharma sector growth to improve in 2011
November 19, 2010Sales and Marketing 2011, IMS, IMS Health, forecast, growth, pharma
2011 should be a better year for pharma as emerging markets and recovering economies will help growth, say analysts at …
Bayer set for 4,500 job cuts
November 19, 2010Research and Development, Sales and Marketing Bayer, Cost cutting, emerging markets
Bayer has announced large scale job losses aimed at saving 800 million euro savings in the coming years.The cuts are …
Denosumab approved for bone cancer use
November 19, 2010Sales and Marketing Amgen, Cancer, Prolia, Xgeva, denosumab
Amgen’s denosumab has been approved in the US to prevent serious bone problems in patients with solid tumour cancers. Denosumab …
Natalie Lewis and Claire Nicholson join the Red Consultancy
November 19, 2010Medical Communications Claire Nicholson, Natalie Lewis, appointment, medical communications, red consultancy, red health
The Red Consultancy has expanded its specialist health team, Red Health, with two new hires. Account director Natalie Lewis (pictured …
CME Spotlight: Medical communications evolves
November 19, 2010CME, CME Spotlight, Continuing medical education, Eugene Pozniak, medical education
I recently attended the first meeting of the MedComms Forum in Oxford. The venue of the Natural History Museum was …
New Men’s Health journal launched
November 19, 2010Medical Communications Trends in Urology and Men's Health, medical education, men's health
A new controlled circulation journal Trends in Urology and Men’s Health has been launched to help promote doctors’ awareness of …
BTG to buy Biocompatibles
November 19, 2010Research and Development BTG, Biocompatibles
BTG is to pay £156 million to acquire Biocompatibles, the drug-device specialists.Established in 1984 and floated in 1995, Biocompatibles specialises …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
